glp-1 drugs and parkinson's disease Incretin insulin signaling as novel therapeutic targets for Alzheimer's and Neuroprotective Actions of Glucagon-Like Peptide-1

have declared that no competing interests exist

The possible mechanisms may involve effects on GLP-1 hormones, the authors of the trial hypothesize, "that are secreted from the gastrointestinal tract and affect appetite by regulating digestive processes and neural signaling in the central nervous system." Medicinal plants are also turning out to be fruitful areas of research

(6) There are analyses indicating that more than half of all arthroplasty patients are obese, with one large retrospective cohort of 8.3 million individuals reporting that 64% of primary total knee arthroplasty (TKA) patients and 49% of primary total hip arthroplasty (THA) patients are obese

Stat Med (2013) 32(16):283749

Evers, A

Overall, JM appears to be in good metabolic control